David Setboun
Chief Operating Officer Alkeus Pharmaceuticals, Inc.
David Setboun, Pharm.D., MBA currently serves as the Chief Operating Officer at Alkeus Pharmaceuticals, Inc. Previously, David held roles such as President at the Academy for Health & Lifespan Research and Executive Vice President & Chief Operating Officer at Brainstorm Cell Therapeutics. David’s extensive experience includes positions at companies like Biogen, AstraZeneca, and Eli Lilly, where David led various teams and initiatives in the pharmaceutical industry. David holds multiple degrees, including an MBA from HEC Paris and a Doctor of Pharmacy from Paris-Sud University.
Seminars
Wednesday 25th March 2026
Fireside Discussion: Navigating Global Differences & Business Decisions in Expanded Access Programs
11:30 am
- Compare regulatory frameworks and access pathways across the US (FDA), Europe (EMA), and other national systems such as France’s ATU
- Explore how approaches to expanded access differ between large pharma and smaller biotech organizations.
- Examine how companies assess the business case and operational feasibility of launching programs in emerging regions, including the Middle East and Latin America
